GeneDx: A Diagnostic Company’s Stock Takes a Hit Amidst Earnings Beat and Guidance Raise
As of this writing, GeneDx (WGS) stock has plummeted 39.3% in morning trading after the company reported its first-quarter earnings results that beat expectations but failed to meet investors' lofty hopes. GeneDx is a health intelligence company specializing in...